Skip to main content

and
  1. Article

    Open Access

    Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1

    In-stent restenosis (ISR) complicates revascularization in the coronary and peripheral arteries. Apolipoprotein A1 (apoA1), the principal protein component of HDL possesses inherent anti-atherosclerotic and an...

    Bahman Hooshdaran, Benjamin B. Pressly, Ivan S. Alferiev in Scientific Reports (2022)

  2. No Access

    Protocol

    Stent-Based Gene Delivery for Coronary Disease

    Percutaneous coronary interventions (PCI) are the mainstay for treatment of advanced coronary disease. A majority of PCI involve deployment of a stent in the affected vascular segment. This chapter introduces ...

    Ivan S. Alferiev, Michael Chorny, Robert L. Wilensky in Cardiac Gene Therapy (2022)

  3. No Access

    Article

    Bioresorbable Scaffolds for Coronary Artery Disease

    The purpose of this review is to present an overview of the recent evidence regarding the use of bioresorbable scaffolds in percutaneous coronary intervention.

    Ashwin Nathan, Taisei Kobayashi, Daniel M. Kolansky in Current Cardiology Reports (2017)

  4. No Access

    Article

    New Insights into the Vulnerable Plaque from Imaging Studies

    The concept of the vulnerable atherosclerotic plaque first developed through histological evaluation of post-mortem coronary arteries has been significantly advanced in recent years by new imaging modalities. ...

    Robert S. Fenning, Robert L. Wilensky in Current Atherosclerosis Reports (2014)

  5. Article

    Intracoronary delivery of bone-marrow-derived stem cells

    Ischemic heart disease is the single greatest killer of Americans and its complications are a major cause of congestive heart failure and ventricular arrhythmias while signifiicantly contributing to increased ...

    Quang T Bui, Zachary M Gertz, Robert L Wilensky in Stem Cell Research & Therapy (2010)

  6. No Access

    Article

    Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors

    Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a calcium-independent phospholipase A2 enzyme secreted by leukocytes and associated with circulating low-density lipoprotein and macrophages in atherosclerotic...

    Ryan J. Chauffe, Robert L. Wilensky, Emile R. Mohler III in Current Atherosclerosis Reports (2010)

  7. No Access

    Article

    Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

    Although increased levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) have been associated with cardiac disease, whether this enzyme has a causal role in the development of atherosclerosis has not bee...

    Robert L Wilensky, Yi Shi, Emile R Mohler III, Damir Hamamdzic in Nature Medicine (2008)

  8. No Access

    Article

    Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

    We performed a genome-wide association scan to search for sequence variants conferring risk of prostate cancer using 1,501 Icelandic men with prostate cancer and 11,290 controls. Follow-up studies involving th...

    Julius Gudmundsson, Patrick Sulem, Valgerdur Steinthorsdottir in Nature Genetics (2007)

  9. No Access

    Article

    A variant in CDKAL1 influences insulin response and risk of type 2 diabetes

    We conducted a genome-wide association study for type 2 diabetes (T2D) in Icelandic cases and controls, and we found that a previously described variant in the transcription factor 7-like 2 gene (TCF7L2) gene con...

    Valgerdur Steinthorsdottir, Gudmar Thorleifsson, Inga Reynisdottir in Nature Genetics (2007)

  10. No Access

    Article

    Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

    We recently described an association between risk of type 2diabetes and variants in the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4), with a population attributable risk (PAR) of 17%–28% in three po...

    Agnar Helgason, Snæbjörn Pálsson, Gudmar Thorleifsson, Struan F A Grant in Nature Genetics (2007)

  11. No Access

    Article

    Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

    We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q1. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-...

    Struan F A Grant, Gudmar Thorleifsson, Inga Reynisdottir in Nature Genetics (2006)

  12. No Access

    Article

    Angiotensin-Receptor Blockers: Revival of the Systemic Prevention of Restenosis?

    Restenosis following percutaneous coronary transluminal angioplasty and stenting remains a significant problem, occurring in 15–50% of patients within 6–9 months of the intervention. Several pharmacological ap...

    Robert L. Wilensky in Cardiovascular Drugs and Therapy (2003)

  13. No Access

    Article

    Gene delivery from a DNA controlled-release stent in porcine coronary arteries

    Expandable intra-arterial stents are widely used for treating coronary disease. We hypothesized that local gene delivery could be achieved with the controlled release of DNA from a polymer coating on an expand...

    Bruce D. Klugherz, Peter L. Jones, **umin Cui, Weiliam Chen in Nature Biotechnology (2000)

  14. No Access

    Chapter

    Acute Myocardial Infarction

    Each year in the United States alone, one and a half million patients suffer an acute myocardial infarction while the annual cost for the prevention and treatment of this illness is estimated to be over 50 bil...

    Kelly A. Spratt, Tanya Y. Huehns in Unstable Coronary Artery Syndromes Pathoph… (1998)

  15. No Access

    Chapter

    Unstable Angina Pectoris

    Cardiovascular disease affects one in five Americans and is the leading cause of mortality in the USA by accounting for 43% of all deaths. In 1994 the cost of cardiovascular disease to the American economy exc...

    Robert L. Wilensky in Unstable Coronary Artery Syndromes Pathoph… (1998)

  16. No Access

    Chapter

    Interventional Approaches to the Treatment of Acute Coronary Ischemic Syndromes

    In 1959 Sones and Shirley [1] introduced selective coronary angiography into clinical medicine heralding an era of visualization of the coronary arterial lumen. Although there is sufficient evidence to indicat...

    Robert L. Wilensky, Elizabeth von der Lohe in Unstable Coronary Artery Syndromes Pathoph… (1998)